Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.
about
Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharidesMethod for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharidesCharacterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparationsSubclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in childrenImmune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity.Comparison of diagnostic criteria for common variable immunodeficiency disorderCorrelates of Protection for M Protein-Based Vaccines against Group A StreptococcusOptimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccineThe effect of age on the response to the pneumococcal polysaccharide vaccine.Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodiesAssessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection.Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccinesEfficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model.Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.Effects of absorption with pneumococcal type 22F polysaccharide on maternal, cord blood, and infant immunoglobulin G antipneumococcal polysaccharide antibodies.Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type bSpecificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children.Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.Memory B cells and pneumococcal antibody after splenectomy.Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine.Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial.Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoireImmunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection.Global control of pneumococcal infections by pneumococcal vaccinesSpecific protein content of pools of plasma for fractionation from different sources: impact of frequency of donationsOpsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines.Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and MaPneumococcal vaccination and revaccination of older adults.Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assayEfficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring coloniesEnzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharidesPneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection.Establishment of a new human pneumococcal standard reference serum, 007sp.Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma.
P2860
Q23918185-E5501246-954F-42B7-BB57-52C7ACDAA2ECQ23919991-9B96CD47-215D-4B73-9830-E647BE2E2A98Q24562005-8E516EAF-E44F-41F7-A059-FC25BD620520Q24684017-D4A9DFF2-6B28-48E5-A80D-BB96F55F9B41Q24812252-D7A13F8C-AFA3-448C-9493-193797B8DF3CQ26859119-FF256583-AD9C-47E9-8CEC-2E116A6FC8CEQ27009175-42FBB423-C9F1-401F-A3EB-95C74A7B942CQ28394642-3E49635E-5DE7-48D4-BED3-56C9C222222AQ33539419-ACC5CC51-25D4-4B53-AAE7-447354CC0EDDQ33593722-67DB840A-6367-400E-B658-7CA7464C78D2Q33593822-BA02D2EF-01DC-4B9C-9C39-FD98A11F8561Q33613509-756F472E-E4BA-4756-9D80-A4927E657AEBQ33706016-CE833585-E073-4DD2-A2B6-7D0E9F26C502Q33724436-D2155F15-976A-47B0-8A03-C89F28ACA215Q33803550-29D95C23-2247-432A-A950-EAABC1CCF086Q33856465-CB19E9A5-8C5B-4128-8F22-73443C44000DQ33909172-7F2C82BD-8E09-4144-AA96-983552B52729Q33943682-5DE8CC00-1E82-4A5B-8B11-8DAA9E3B554BQ33944443-41A76FD5-0E4F-4FE6-89E0-F39FB53E847DQ34033855-3ACC883D-32AB-48E8-B7C1-59697D956D95Q34056334-4DAF2458-1D56-4434-BCEE-29D4D20035CDQ34072420-B4C22921-D709-4F89-8BAF-D6FC5DF45914Q34082225-69B6DBB9-B5F4-4FB9-BFA5-C8EBF1B40D9BQ34111761-ED6309BC-44F0-4846-A193-CCEF2EAA4F5AQ34291235-1E74F22D-D6EF-4C20-9A24-9640DBC5A9C5Q34311579-FCC28676-EEA0-4626-898A-DD2363507510Q34375742-4550A3E8-76F9-405C-8711-67027619A447Q34401639-B6CFB89F-BD3B-4A2D-8713-FFA6975AB82EQ34444503-F1C73B54-67CA-4D7B-A11D-0DB15BF21262Q34738780-FE3E7ED2-6733-419C-8092-60A5A9B2F551Q34779011-1E5E0ADC-A8C0-41BA-8020-CBDDE53A93E3Q34867264-4E25BF9F-AFC6-4279-86FB-4191C67C1433Q34926870-F1965B5D-5A62-42F2-A6B2-557FE121AF12Q34975051-66C023E9-C3B5-451A-BF2A-085F2A440A86Q35139935-01E339DA-EF29-4AE4-AA61-C172CB27CE3CQ35139987-63815E9C-3B86-4D9D-AFF2-732B9E1AAA0BQ35194417-402DF0DA-BA9A-45A2-B25D-662441F85B5FQ35271202-EAA2C093-3B04-41BF-B49F-55DA2E227964Q35541552-DB4477FF-D061-4834-95AF-9E377535A534Q35561607-E80C4E84-87B5-4E33-8C3A-E6387134B10C
P2860
Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Pneumococcal type 22f polysacc ...... me-linked immunosorbent assay.
@en
Pneumococcal type 22f polysacc ...... me-linked immunosorbent assay.
@nl
type
label
Pneumococcal type 22f polysacc ...... me-linked immunosorbent assay.
@en
Pneumococcal type 22f polysacc ...... me-linked immunosorbent assay.
@nl
prefLabel
Pneumococcal type 22f polysacc ...... me-linked immunosorbent assay.
@en
Pneumococcal type 22f polysacc ...... me-linked immunosorbent assay.
@nl
P2860
P1476
Pneumococcal type 22f polysacc ...... me-linked immunosorbent assay.
@en
P2093
C E Frasch
N F Concepcion
P2860
P304
P356
10.1128/CDLI.8.2.266-272.2001
P577
2001-03-01T00:00:00Z